Gelstat 

$0
6
+$0+20% Friday 20:00

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
900,000
Avg. Volume
1,132,652
Mkt Cap
1.12M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0
-0
-0
0
Expected EPS
N/A
Actual EPS
-0.0004

Financials

-106.57%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
700,000Revenue
-746,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GSAC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with Gelstat in the development and marketing of medications for various health conditions, including those Gelstat targets.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceutical sector, directly competing with Gelstat in areas such as pain management and healthcare solutions.
Novartis
NVS
Mkt Cap237.61B
Novartis is a multinational pharmaceutical company that offers a wide range of healthcare products, competing with Gelstat in the pharmaceutical and healthcare market.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a healthcare company that produces pharmaceuticals and vaccines, competing with Gelstat in the development of treatments for various conditions.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that competes with Gelstat in the pharmaceutical industry, particularly in the areas of drug development and sales.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a biopharmaceutical company that competes with Gelstat in the research, development, and marketing of pharmaceutical products.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology company that competes with Gelstat in the development of innovative therapies and pharmaceutical products.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Gelstat in the discovery, development, and delivery of medicines.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company is a global pharmaceutical company that competes with Gelstat in developing and marketing medications for various health conditions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries is a global pharmaceutical company that competes with Gelstat in generic and specialty medicines, covering a broad range of therapeutic areas.

About

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation is headquartered in Palm City, Florida.
Show more...
CEO
Mr. Javier G. Acosta
Employees
2
Country
US
ISIN
US3685331056

Listings

0 Comments

Share your thoughts

FAQ

What is Gelstat stock price today?
The current price of GSAC is $0 USD — it has increased by +20% in the past 24 hours. Watch Gelstat stock price performance more closely on the chart.
What is Gelstat stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Gelstat stocks are traded under the ticker GSAC.
What is Gelstat market cap?
Today Gelstat has the market capitalization of 1.12M
What were Gelstat earnings last quarter?
GSAC earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Gelstat revenue for the last year?
Gelstat revenue for the last year amounts to 700,000 USD.
What is Gelstat net income for the last year?
GSAC net income for the last year is -746,000 USD.
How many employees does Gelstat have?
As of April 01, 2026, the company has 2 employees.
In which sector is Gelstat located?
Gelstat operates in the Health Care sector.
When did Gelstat complete a stock split?
The last stock split for Gelstat was on October 21, 2003 with a ratio of 2:1.
Where is Gelstat headquartered?
Gelstat is headquartered in Palm City, US.